StartUp Health NOW Podcast

Edamam CEO: Why Food as Medicine Has Hit a Market Tipping Point & Opportunities in the Space

6 snips
Jan 31, 2025
Victor Penev, CEO and Founder of Edamam, dives into the promising world of 'food as medicine,' exploring how it’s finally gaining traction in healthcare. He discusses the impact of GLP-1 medications and generative AI in reshaping nutrition strategies. Penev highlights the growing demand for clean, sustainable food—especially among Gen Z—and envisions a future where AI provides personalized dietary recommendations. Funding opportunities and innovative business models are also on the horizon, marking a pivotal moment for nutritional science.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

GLP-1s and Food as Medicine

  • GLP-1 medications create a market opportunity for food as medicine.
  • People desire guidance on food choices before, during, and after taking GLP-1 drugs.
INSIGHT

Food as Medicine Business Model

  • The biggest challenge for food as medicine is the unclear business model.
  • It's uncertain who will pay: health plans, pharma, grocery stores, or consumers.
INSIGHT

Challenges in Food as Medicine Research

  • Conducting controlled trials for food as medicine interventions is challenging.
  • The food industry lacks the organization and funding of the pharmaceutical industry.
Get the Snipd Podcast app to discover more snips from this episode
Get the app